Title:
COMPOUND HAVING KINASE INHIBITING ACTIVITY, METHOD OF PREPARING SAME, AND USE OF SAME
Document Type and Number:
WIPO Patent Application WO/2016/192630
Kind Code:
A1
Abstract:
Disclosed are a compound shown in a general formula I, or a pharmaceutically acceptable salt thereof, or an enantiomer, a diastereosiomer, a tautomer, a solvate, a polymorph or a prodrug thereof, a method for preparing same, and an pharmaceutical application thereof, where definitions of groups are discussed in the specification. The compound of the present invention has desirable exemplary CDK kinase inhibiting activity, and has relatively good development and application prospects.
More Like This:
Inventors:
WAN HUIXIN (CN)
GENG MEIYU (CN)
CHEN PENG (CN)
HUANG MIN (CN)
JIANG LEI (CN)
CAO JIANHUA (CN)
CHEN ZHUXI (CN)
LI LEI (CN)
TANG SHUAI (CN)
SU YI (CN)
CAO WENJIE (CN)
LIU LEI (CN)
CHEN CHUNLIN (CN)
DING JIAN (CN)
GENG MEIYU (CN)
CHEN PENG (CN)
HUANG MIN (CN)
JIANG LEI (CN)
CAO JIANHUA (CN)
CHEN ZHUXI (CN)
LI LEI (CN)
TANG SHUAI (CN)
SU YI (CN)
CAO WENJIE (CN)
LIU LEI (CN)
CHEN CHUNLIN (CN)
DING JIAN (CN)
Application Number:
PCT/CN2016/084356
Publication Date:
December 08, 2016
Filing Date:
June 01, 2016
Export Citation:
Assignee:
SHANGHAI INST MATERIA MEDICA CAS (CN)
SHANGHAI HAIHE PHARMACEUTICAL CO LTD (CN)
SHANGHAI HAIHE PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D401/14; A61K31/506; A61P35/00
Domestic Patent References:
WO2016015604A1 | 2016-02-04 | |||
WO2003030909A1 | 2003-04-17 | |||
WO2012149528A1 | 2012-11-01 |
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
上海一平知识产权代理有限公司 (CN)
上海一平知识产权代理有限公司 (CN)
Download PDF: